A Trial of Negative Ion Generation Versus Light-Emitting Diode Phototherapy for Seasonal Affective Disorder (SAD)

NCT00809523 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 106

Last updated 2013-03-06

Study results available
· View outcomes & findings →

Summary

This is a randomized, controlled clinical trial of inactivated negative ion generation or light-emitting photodiode therapy for Seasonal Affective Disorder (SAD, winter depression), for subjects with a DSM IV diagnosis of Major Depression, with Seasonal Pattern, Winter type, to examine efficacy of treatments for this condition. The trial has a 1 week baseline phase and a 4 week treatment phase.

Conditions

  • Seasonal Affective Disorder

Interventions

DEVICE

Negative Ion Generator

Equivalent exposure to inactivated Negative Ion Generator

DEVICE

Light-emitting Photodiode light treatment device

Light-emitting Photodiode light treatment device, used for 30 min before 8 am

Sponsors & Collaborators

  • The Litebook Company Ltd.

    collaborator INDUSTRY
  • University of British Columbia

    collaborator OTHER
  • McGill University Health Centre/Research Institute of the McGill University Health Centre

    collaborator OTHER
  • Harvard University

    collaborator OTHER
  • University of Toronto

    collaborator OTHER
  • Clinical Associates Research, Maryland

    collaborator NETWORK
  • Dalhousie University

    collaborator OTHER
  • Yale University

    lead OTHER

Principal Investigators

  • Paul Desan, MD, PhD · Yale University

  • Raymond Lam, MD · University of British Columbia, Vancouver, Canada

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-12-31
Primary Completion
2010-04-30
Completion
2010-04-30

Countries

  • United States
  • Canada
  • Netherlands

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00809523 on ClinicalTrials.gov